289 related articles for article (PubMed ID: 29958527)
1. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I; Szadkowski M
Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I
Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
[TBL] [Abstract][Full Text] [Related]
3. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
Moore CP; McHugh JB; Thorne JG; Phillips TE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
Bounous DI; Krenzer KL; Kaswan RL; Hirsh SG
Adv Exp Med Biol; 1998; 438():997-1000. PubMed ID: 9635001
[No Abstract] [Full Text] [Related]
6. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of corneal impression cytology in dogs and its application in the diagnosis of keratoconjunctivitis sicca.
Lejarza-Ilaro M; Rodriguez-Alvaro A; Sanchez-Maldonado B; Gonzalez-Alonso-Alegre E
Vet Rec; 2019 Jun; 184(22):678. PubMed ID: 31019006
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs.
Zulim LFDC; Nai GA; Giuffrida R; Pereira CSG; Benguella H; Cruz AG; Foglia BTD; Batista ADS; Andrade SF
Arq Bras Oftalmol; 2018; 81(4):293-301. PubMed ID: 29995121
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
13. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
[TBL] [Abstract][Full Text] [Related]
14. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
Gao J; Schwalb TA; Addeo JV; Ghosn CR; Stern ME
Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of HL036 versus Cyclosporine A in the Treatment of Naturally Occurring Canine Keratoconjunctivitis Sicca.
Lee HB; Choi HJ; Cho SM; Kang S; Ahn HK; Song YJ; Kim YJ; Son WC
Curr Eye Res; 2018 Jul; 43(7):889-895. PubMed ID: 29634381
[TBL] [Abstract][Full Text] [Related]
16. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
[TBL] [Abstract][Full Text] [Related]
17. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
18. Scanning electron microscopy of experimental keratoconjunctivitis sicca in dogs: cornea and bulbar conjunctiva.
Kern TJ; Erb HN; Schaedler JM; Dougherty EP
Vet Pathol; 1988 Nov; 25(6):468-74. PubMed ID: 3212890
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.
Coassin M; Lambiase A; Costa N; De Gregorio A; Sgrulletta R; Sacchetti M; Aloe L; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2005 Feb; 243(2):151-5. PubMed ID: 15650854
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
Nell B; Walde I; Billich A; Vit P; Meingassner JG
Vet Ophthalmol; 2005; 8(1):39-46. PubMed ID: 15644099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
